Casma Therapeutics Alternatives & Competitors
12 companies similar to Casma Therapeutics — With deep expertise in cellular degradation, Casma is advancing targeted therapi...
Companies similar to Casma Therapeutics
Angitia Biopharmaceuticals
Developing innovative medicines to address serious musculoskeletal diseases
Westlake Village, United...
Acceleron Pharma
Accelerating drug discovery to transform patients' lives
Cambridge, United States
AATec Medical
Pioneering biotech solutions for inflammatory disorders, viral infections, and rare diseas...
Track all Casma Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Myrobalan Therapeutics
Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS...
Medford, United States
Corlieve Therapeutics
At Corlieve, we are focused on bringing novel therapeutic options to patients with severe...
Paris, France
Cajal Therapeutics
Cajal Therapeutics is a Seattle biotechnology company dedicated to developing innovative m...
Seattle, United States
GeNeuro SA
We focus on Human Endogenous Retroviruses (#HERVs) to fight neurodegeneration in #MS, #ALS...
THRASOS LIMITED
Pioneering targeted therapies to prevent and treat severe organ failure, with a focus on k...
Petra Pharma
Pioneering novel therapies to address cancer and metabolic disorders by targeting essentia...
Symic Bio
A new category of therapeutics based on extracellular matrix biology
San Francisco, United Sta...
About Casma Therapeutics
Casma Therapeutics, founded in 2018 and headquartered in the United States, is shaping the future of the Biotechnology and Health Care industries through innovative research. With the slogan, "Harnessing the power of autophagy to bring cures to patients with serious diseases," the company focuses on utilizing the natur...
Reprogramming autophagy for disease treatment, Development of novel cellular degradation approaches, Autophagy-based drug discovery and development, Target-specific autophagic degradation
Healthcare Professionals, Biopharmaceutical Researchers, Patients with Oncology, Inflammation, Neurodegeneration, and Metabolic Disorders
Autophagy, Drug Discovery, Lysosomal Storage Disorders, Muscle Disorders, Inflammatory Disorders, Neurodegeneration, Cellular Processes, Medicine Development, Therapeutics, Medical Research, Biopharmaceuticals
B2B
Licensing, Performance Based, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Casma Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Casma Therapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
